- About us
- A new Institute dedicated to combating leukemia
- Our news
- Support us
- You are
- Patients and relatives
- To receive care and support
- Become an expert patient
- Discover the Leukemia Institute
- Researchers
- Research
- Clinical trials
- Discover the Leukemia Institute
- Healthcare professionals
- Refer a patient
- Our clinical research
- Discover the Leukemia Institute
- Industry partners
- Discover the Leukemia Institute
- Translational research
- Donors
- Support us
- Discover the Leukemia Institute
- Care
- Patient care
- Our clinical services
- Our medical laboratories
- Patient information
- Research
- Our research teams
- Our technological platforms
- Our clinical research
The Leukemia Institute: key figures
1stleukemia treatment and research center in France
Research teams
14Clinical departments
80Ongoing clinical trials
Our 4 areas of expertise
Innovation
Innovative patents and industrial collaborations, including through our drug screening platform
Our news
Researchers10th anniversary of the Jean Bernard building
Read the article
PatientsPodcast “Bone marrow transplantation: when the new immune system runs out of control”
Read the article
Non classéPr Hugues de Thé, Shaw Prize 2026 laureate
Read the article
Industry partnersSecond edition of LEUKEMIA 360
Read the articleOur featured research projects
Intrinsic and extrinsic effects of the immune microenvironment in myelodysplastic syndromes
This project employs in vitro and ex vivo models to decipher how stromal and blast cells alter bone marrow NK cell-mediated immunosurveillance during MDS initiation and progression.
E-selectin antagonists in leukemia
Evaluation of molecules to block leukemia-microenvironment interaction and restore chemosensitivity.
Targeting the myeloid-specific isoform PIK3CG using heterobifunctional PROTAC-type degrader molecules to block AML progression.
In the press
- Our technological platforms
- Our clinical services
- Discover the Leukemia Institute
- Translational research
- Our clinical research
- Clinical trials
- Become an expert patient
- To receive care and support
- Our news
- A new Institute dedicated to combating leukemia
